Background/Objectives: Meningitis due to the species Streptococcus is a severe central nervous system infection caused by various microorganisms belonging to Streptococcus spp. Its accurate identification is critical for effective clinical management. This study aimed to identify Streptococcus spp. causing meningitis in Greece over a nine-year period using PCR and sequencing-based methods. Methods: A total of 189 clinical samples, collected between 2015 and 2024 from patients suffering from meningitis and/or septicemia, were analyzed by the use of a combination of multiplex polymerase chain reaction (PCR) assays and tuf gene sequencing for further species identification. Results: Sample analysis identified 70 samples as S. pyogenes (18.52%) (GAS) and S. agalactiae (18.52%) (GBS), while 119 (62.96%) were recorded as non-typable Streptococcus spp. Further analysis using sequencing methods revealed that the most frequent Streptococcus spp. belonged to the mitis group (42.86%) and the pyogenic group (20.17%). A higher prevalence was observed in children aged 0–14 years old and adults over 50 years old. Conclusions: This study highlights the use of molecular diagnostics in identifying other Streptococcus spp., providing insights into age-related susceptibility and epidemiological trends. Future studies are needed to explore the pathogenic role of the identified Lactococcus spp.
Infectious diseases remain a leading cause of global morbidity and mortality, underscoring the need for rapid, accurate, and comprehensive diagnostic approaches. Advances in omics technologies have evolved our ability to detect, characterize, and monitor pathogens. Together, these technologies offer a systems-level perspective that enhances diagnostic accuracy which can be applied both in clinical and public health laboratories, to ameliorate infectious diseases policies and strategies. Despite significant progress, challenges remain in terms of cost, data integration, standardization, and clinical translation. Future directions include the development of multi-omics platforms, real-time sequencing technologies, and robust bioinformatics pipelines to accelerate implementation in routine clinical practice. This review highlights the current landscape, key applications, and future potential of omics-based diagnostics in combating infectious diseases.